Literature DB >> 18845436

N-Glycine-sulfonamides as potent dual orexin 1/orexin 2 receptor antagonists.

Hamed Aissaoui1, Ralf Koberstein, Cornelia Zumbrunn, John Gatfield, Catherine Brisbare-Roch, Francois Jenck, Alexander Treiber, Christoph Boss.   

Abstract

A series of dual OX(1)R/OX(2)R orexin antagonists was prepared based on a N-glycine-sulfonamide core. SAR studies of a screening hit led to compounds with low nanomolar affinity for both receptors and good oral bioavailability. One of these compounds, 47, has demonstrated in vivo activity in rats following oral administration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18845436     DOI: 10.1016/j.bmcl.2008.09.079

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  5 in total

Review 1.  Chemistry and biology of orexin signaling.

Authors:  Thomas Kodadek; Di Cai
Journal:  Mol Biosyst       Date:  2010-06-07

2.  Orexin regulates bone remodeling via a dominant positive central action and a subordinate negative peripheral action.

Authors:  Wei Wei; Toshiyuki Motoike; Jing Y Krzeszinski; Zixue Jin; Xian-Jin Xie; Paul C Dechow; Masashi Yanagisawa; Yihong Wan
Journal:  Cell Metab       Date:  2014-05-01       Impact factor: 27.287

3.  Room temperature synthesis and antibacterial activity of new sulfonamides containing n,n-diethyl-substituted amido moieties.

Authors:  Olayinka O Ajani; Oluwole B Familoni; Feipeng Wu; Johnbull O Echeme; Zheng Sujiang
Journal:  Int J Med Chem       Date:  2012-10-17

4.  New carboxamide derivatives bearing benzenesulphonamide as a selective COX-II inhibitor: Design, synthesis and structure-activity relationship.

Authors:  David Izuchukwu Ugwu; Uchechukwu Chris Okoro; Hilal Ahmad
Journal:  PLoS One       Date:  2017-09-18       Impact factor: 3.240

5.  Biological Activity Evaluation of Some New Benzenesulphonamide Derivatives.

Authors:  Florence Uchenna Eze; Uchechukwu Christopher Okoro; David Izuchukwu Ugwu; Sunday N Okafor
Journal:  Front Chem       Date:  2019-09-18       Impact factor: 5.221

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.